Skip to content
Company Analysis

Allurion Technologies, Inc. ALUR

A comprehensive view of key metrics, scores, and financial health for Allurion Technologies, Inc.

Overview of Allurion Technologies Inc.

ALUR NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Allurion Technologies Inc. (ALUR), is a Micro Cap company, in the Medical Devices industry, last closed at $0.71, about 271.7% undervalued vs fair value, -70.9% 1Y return, ranked 1047/1122 in sector.
USD 0.71
-0.10%
(Delayed)
• Vol 90d: 245.1%
52-Week Range
Market Cap
$11.85M
Enterprise Value
$35.48M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 87%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.allurion.com
HQ Natick, MA
Employees 134
Fiscal year Dec 31

Next Events

Earnings Aug 12 Estimated

Fair Value Snapshot

Bear Base Bull
$-2
$-1
$-1
Current: $0.71

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$15.2M
-52.6%%
Gross Profit
$9.6M
-55.5%%
Operating Income (GAAP)
$-30.2M
39.9%%
EBITDA
$-27.7M
-760.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
62.8%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Allurion Technologies, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
42
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
59
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing ALUR's balance between Growth (23.0%), Profitability (41.2%), and Safety (35.8%). Growth 23% Safety 36% Profitability 41%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

28th percentile vs peers
28
Key Signals
EPS Growth YoY 94.6% 89p Revenue CAGR 3Y -5.7% 18p Rev Growth YoY -39.9% 7p Asset Growth YoY -54.2% 3p TSR -99.7% 1p
Strengths
  • EPS Growth YoY in top 20% of peers (94.6%, 89th percentile)
  • ROIC in top 20% of peers (93.8%, 95th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Debt/Assets in top 20% of peers (1.16, 96th percentile)
Risks
  • Rev Growth YoY in bottom 20% of peers (-39.9%)

Profitability

50th percentile vs peers
51
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

44th percentile vs peers
44
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Allurion Technologies, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-1.41
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000